Journal articles on the topic 'Anthracyclines'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Anthracyclines.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Sorensen, K., G. Levitt, D. Sebag-Montefiore, C. Bull, and I. Sullivan. "Cardiac function in Wilms' tumor survivors." Journal of Clinical Oncology 13, no. 7 (July 1995): 1546–56. http://dx.doi.org/10.1200/jco.1995.13.7.1546.
Full textKrook, James Edward, Akhil Kumar, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, Val Fishman, Sharon Davis, et al. "Community use of anthracyclines in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 1080. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1080.
Full textKumar, Akhil, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, James Edward Krook, Val Fishman, Sharon Davis, et al. "Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC)." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e11609-e11609. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e11609.
Full textNeppelenbroek, Suzanne I. M., Yvonne M. Geurts, Berthe M. P. Aleman, Cecile P. M. Janus, Saskia E. Rademakers, Roel J. de Weijer, Richard W. M. Van Der Maazen, et al. "Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 12074. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.12074.
Full textBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays, et al. "Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group." Journal of Clinical Oncology 30, no. 13 (May 1, 2012): 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Full textRybczyńska-Tkaczyk, Kamila. "Enhanced Efficiency of the Removal of Cytostatic Anthracycline Drugs Using Immobilized Mycelium of Bjerkandera adusta CCBAS 930." Molecules 26, no. 22 (November 12, 2021): 6842. http://dx.doi.org/10.3390/molecules26226842.
Full textTorkkell, Sirke, Tero Kunnari, Kaisa Palmu, Juha Hakala, Pekka Mäntsälä, and Kristiina Ylihonko. "Identification of a Cyclase Gene Dictating the C-9 Stereochemistry of Anthracyclines from Streptomyces nogalater." Antimicrobial Agents and Chemotherapy 44, no. 2 (February 1, 2000): 396–99. http://dx.doi.org/10.1128/aac.44.2.396-399.2000.
Full textKrell, J., C. Harper-Wynne, D. Miles, V. Misra, S. Cleator, D. Krell, and C. Palmieri. "What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 1072. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1072.
Full textChen, Wei-Wu, Twan Ying Chang, Shu-Min Huang, Ching-Hung Lin, Chiun Hsu, Ann-Lii Cheng, and Yen-Shen Lu. "The first two lines of chemotherapy for anthracycline-naïve metastatic breast cancer: A comparative study of efficacy between anthracyclines and nonanthracyclines." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 1061. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1061.
Full textGianni, Luca, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, and Gabriel N. Hortobagyi. "Role of Anthracyclines in the Treatment of Early Breast Cancer." Journal of Clinical Oncology 27, no. 28 (October 1, 2009): 4798–808. http://dx.doi.org/10.1200/jco.2008.21.4791.
Full textSuarato, Antonino, Francesco Angelucci, and Cristina Geroni. "Ring-B Modified Anthracyclines." Current Pharmaceutical Design 5, no. 3 (March 1999): 217–27. http://dx.doi.org/10.2174/1381612805666230109215627.
Full textDozic, Sanela, Erin J. Howden, James R. Bell, Kimberley M. Mellor, Lea M. D. Delbridge, and Kate L. Weeks. "Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy." Cells 12, no. 9 (May 4, 2023): 1312. http://dx.doi.org/10.3390/cells12091312.
Full textGennari, A., M. Sormani, M. Costantini, P. Pronzato, R. Rosso, and P. Bruzzi. "Anthracycline regimens versus CMF in the adjuvant treatment of early breast cancer (EBC): A matter of difference." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 569. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.569.
Full textEgas Bejar, Daniela E., Joy M. Fulbright, Fernando F. Corrales-Medina, Mary E. Irwin, Blake Johnson, and Joya Chandra. "Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects." Blood 122, no. 21 (November 15, 2013): 1293. http://dx.doi.org/10.1182/blood.v122.21.1293.1293.
Full textBehrouzian, Mahsa, Babak Najibi, Sabahat Haghi, Chehreh Mahdavi, Kaveh Jaseb, and Ehsan Ghaedi. "Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose." Current Drug Therapy 15, no. 1 (January 14, 2020): 78–84. http://dx.doi.org/10.2174/1574885514666190311145607.
Full textKhan, Meraj A., Adam D’Ovidio, Harvard Tran, and Nades Palaniyar. "Anthracyclines Suppress Both NADPH Oxidase- Dependent and -Independent NETosis in Human Neutrophils." Cancers 11, no. 9 (September 7, 2019): 1328. http://dx.doi.org/10.3390/cancers11091328.
Full textde Vries, Elisabeth G. E., and Jan G. Zijlstra. "Morpholinyl anthracyclines: Option for reversal of anthracycline resistance." European Journal of Cancer and Clinical Oncology 26, no. 6 (January 1990): 659–60. http://dx.doi.org/10.1016/0277-5379(90)90110-f.
Full textMarinello, Jessica, Maria Delcuratolo, and Giovanni Capranico. "Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives." International Journal of Molecular Sciences 19, no. 11 (November 6, 2018): 3480. http://dx.doi.org/10.3390/ijms19113480.
Full textMontaigne, David, Christopher Hurt, and Remi Neviere. "Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies." Biochemistry Research International 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/951539.
Full textQiao, Xiaohang, Sabina Y. van der Zanden, Dennis P. A. Wander, Daniel M. Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne van Duikeren, et al. "Uncoupling DNA damage from chromatin damage to detoxify doxorubicin." Proceedings of the National Academy of Sciences 117, no. 26 (June 17, 2020): 15182–92. http://dx.doi.org/10.1073/pnas.1922072117.
Full textHerzig, R. H., H. M. Lazarus, S. N. Wolff, G. L. Phillips, and G. P. Herzig. "High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia." Journal of Clinical Oncology 3, no. 7 (July 1985): 992–97. http://dx.doi.org/10.1200/jco.1985.3.7.992.
Full textLevina, V. D., M. G. Poltavskaya, V. P. Sedov, P. Sh Chomakhidze, L. V. Bolotina, T. I. Deshkina, M. D. Kuklina, et al. "The role of left ventricle global longitudinal srain in prediction of chemotherapy — induced cardiotoxicity in breast cancer patients treated by low and moderate cumulative doses of anthracyclines." Medical alphabet, no. 33 (January 12, 2023): 19–26. http://dx.doi.org/10.33667/2078-5631-2022-33-19-26.
Full textAl-Batran, S., M. Scholz, and E. Jäger. "Anthracycline-rechallenge using pegylated liposomal doxorubicin (PLD) in previously treated patients with metastatic breast cancer (MBC): A meta-analysis using pooled individual data from four prospective trials." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 1047. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1047.
Full textMenna, Pierantonio, and Emanuela Salvatorelli. "Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview." Chemotherapy 62, no. 3 (2017): 159–68. http://dx.doi.org/10.1159/000455823.
Full textVeiga, Lene H. S., Rochelle E. Curtis, Lindsay M. Morton, Diana Withrow, Rebecca M. Howell, Susan A. Smith, Rita Weathers, et al. "Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS)." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 10053. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10053.
Full textAplenc, R., J. Blanco, W. Leisenring, S. Davies, M. Relling, L. Robison, C. Sklar, M. Stovall, and S. Bhatia. "Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS)." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 9004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9004.
Full textArmenian, Saro, and Smita Bhatia. "Predicting and Preventing Anthracycline-Related Cardiotoxicity." American Society of Clinical Oncology Educational Book, no. 38 (May 2018): 3–12. http://dx.doi.org/10.1200/edbk_100015.
Full textMata, Danilo Giffoni M. M., Matthew Castelo, Rinku Sutradhar, Lena Nguyen, Neil Faught, Danielle Rodin, Ezra Hahn, et al. "Abstract P4-06-10: Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? – A Real World Comparison in the Neoadjuvant Setting." Cancer Research 83, no. 5_Supplement (March 1, 2023): P4–06–10—P4–06–10. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-06-10.
Full textHamilton, Joseph Z., Kerry Klussman, Rebecca Mahzereh, Jessica Simmons, Michelle Ulrich, Shyra J. Gardai, Peter D. Senter, and Patrick J. Burke. "Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs." Cancer Research 83, no. 7_Supplement (April 4, 2023): 2013. http://dx.doi.org/10.1158/1538-7445.am2023-2013.
Full textKremer, L. C. M., E. C. van Dalen, M. Offringa, J. Ottenkamp, and P. A. Voûte. "Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study." Journal of Clinical Oncology 19, no. 1 (January 1, 2001): 191–96. http://dx.doi.org/10.1200/jco.2001.19.1.191.
Full textFulbright, Joy Marie, and Joya Chandra. "“Limiting Anthracycline-Induced Cardiotoxicity Using Amrubicin in Leukemia Systems”." Blood 114, no. 22 (November 20, 2009): 3760. http://dx.doi.org/10.1182/blood.v114.22.3760.3760.
Full textHarahsheh, Ashraf, Sanjeev Aggarwal, Michael D. Pettersen, and Thomas L’Ecuyer. "Diastolic function in anthracycline-treated children." Cardiology in the Young 25, no. 6 (September 23, 2014): 1130–35. http://dx.doi.org/10.1017/s1047951114001760.
Full textPiccart-Gebhart, Martine J., Tomasz Burzykowski, Marc Buyse, George Sledge, James Carmichael, Hans-Joachim Lück, John R. Mackey, et al. "Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer." Journal of Clinical Oncology 26, no. 12 (April 20, 2008): 1980–86. http://dx.doi.org/10.1200/jco.2007.10.8399.
Full textMegias-Vericat, Juan Eduardo, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González, et al. "DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA." Mediterranean Journal of Hematology and Infectious Diseases 11, no. 1 (February 26, 2019): e2019016. http://dx.doi.org/10.4084/mjhid.2019.016.
Full textCreutzig, Ursula, Sylke Diekamp, Martin Zimmermann, and Dirk Reinhardt. "Long Term Data on Anthracycline Cardiotoxicity in 547 Children with AML." Blood 108, no. 11 (November 1, 2006): 2014. http://dx.doi.org/10.1182/blood.v108.11.2014.2014.
Full textCheong, Alison, Sean McGrath, and Suzanne Cutts. "Anthracyclines." WikiJournal of Medicine 5, no. 1 (December 6, 2018): 1. http://dx.doi.org/10.15347/wjm/2018.001.
Full text&NA;. "Anthracyclines." Reactions Weekly &NA;, no. 433 (January 1993): 6. http://dx.doi.org/10.2165/00128415-199304330-00012.
Full text&NA;. "Anthracyclines." Reactions Weekly &NA;, no. 371 (October 1991): 4–5. http://dx.doi.org/10.2165/00128415-199103710-00011.
Full text&NA;. "Anthracyclines." Reactions Weekly &NA;, no. 1293 (March 2010): 9–10. http://dx.doi.org/10.2165/00128415-201012930-00021.
Full textDesmedt, Christine, Angelo Di Leo, Evandro de Azambuja, Denis Larsimont, Benjamin Haibe-Kains, Jean Selleslags, Suzette Delaloge, et al. "Multifactorial Approach to Predicting Resistance to Anthracyclines." Journal of Clinical Oncology 29, no. 12 (April 20, 2011): 1578–86. http://dx.doi.org/10.1200/jco.2010.31.2231.
Full textCheah, Irwin K., Richard M. Y. Tang, Xiaoyuan Wang, Karishma Sachaphibulkij, Suet Yen Chong, Lina H. K. Lim, Jiong-Wei Wang, and Barry Halliwell. "Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine." Antioxidants 12, no. 2 (January 30, 2023): 320. http://dx.doi.org/10.3390/antiox12020320.
Full textAttina’, Giorgio, Silvia Triarico, Alberto Romano, Palma Maurizi, Stefano Mastrangelo, and Antonio Ruggiero. "Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment." Biomedical and Pharmacology Journal 15, no. 3 (September 29, 2022): 1311–21. http://dx.doi.org/10.13005/bpj/2468.
Full textPaukovcekova, Silvia, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda, and Renata Veselska. "Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors." International Journal of Molecular Sciences 23, no. 15 (August 1, 2022): 8549. http://dx.doi.org/10.3390/ijms23158549.
Full textFranco, Vivian I., Jacqueline M. Henkel, Tracie L. Miller, and Steven E. Lipshultz. "Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines." Cardiology Research and Practice 2011 (2011): 1–13. http://dx.doi.org/10.4061/2011/134679.
Full textPuzzovivo, Agata, Agnese Maria Fioretti, Carla Minoia, Roberta Villoni, Santa Carbonara, Giusi Graziano, Fabio Pavone, Attilio Guarini, and Stefano Oliva. "Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin’s Lymphoma: The Tei Index Evaluation." Journal of Personalized Medicine 12, no. 2 (February 16, 2022): 290. http://dx.doi.org/10.3390/jpm12020290.
Full textAngelotti, Austin, Deena Snoke, Rachel Cole, Genevieve Sparagna, and Martha Belury. "Characterizing Cardiolipin Species in the Hearts After Anthracycline Administration." Current Developments in Nutrition 5, Supplement_2 (June 2021): 934. http://dx.doi.org/10.1093/cdn/nzab050_001.
Full textTagawa, Michihito, Genya Shimbo, Akiko Uemura, and Kotaro Matsumoto. "Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines." Open Veterinary Journal 11, no. 1 (March 19, 2021): 6–10. http://dx.doi.org/10.4314/ovj.v11i1.2.
Full textGschwantler-Kaulich, D., A. Fink-Retter, T. Bachrich, M. Ledesma, E. Ruecklinger, E. Kubista, and C. F. Singer. "Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 11098. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11098.
Full textDadson, Keith, Oscar Calvillo-Argüelles, Paaladinesh Thavendiranathan, and Filio Billia. "Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms." Clinical Science 134, no. 13 (July 2020): 1859–85. http://dx.doi.org/10.1042/cs20190653.
Full textChong, Wei, Huikun Zhang, Zhifang Guo, Limin Yang, Ying Shao, Xiaoli Liu, Yawen Zhao, et al. "Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity." Cell Death & Differentiation 28, no. 1 (August 19, 2020): 382–400. http://dx.doi.org/10.1038/s41418-020-00607-9.
Full text